MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bastepe, M.
Right arrow Articles by Ashby, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bastepe, M.
Right arrow Articles by Ashby, B.

0026-895X/97/020343-07$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 51:343-349 (1997).

The Long Cytoplasmic Carboxyl Terminus of the Prostaglandin E2 Receptor EP4 Subtype Is Essential for Agonist-Induced Desensitization

Murat Bastepe and Barrie Ashby

Department of Pharmacology (M.B., B.A.) and Sol Sherry Thrombosis Research Center (B.A.), Temple University School of Medicine, Philadelphia, Pennsylvania 19140

The 488-amino acid human prostaglandin E2 receptor EP4 subtype, which couples to stimulation of adenylyl cyclase, shares the major structural features of G protein-coupled receptors, having seven putative transmembrane domains, an extracellular amino terminus, and a cytoplasmic carboxyl terminus. The latter is composed of 156 amino acids and contains 38 serine and threonine residues, which are potential phosphorylation sites. The carboxyl terminus may be important in receptor function; in some receptors, truncation of the cytoplasmic tail abolishes desensitization. In others, truncation leads to constitutive activity, and in other receptors, truncation has no effect on receptor function. To investigate the role of the long cytoplasmic tail of the EP4 receptor, we constructed a mutant EP4 that lacks the last 138 amino acids at the carboxyl terminus, including 36 serine and threonine residues. The truncated EP4 receptor was stably expressed in Chinese hamster ovary cells at levels comparable to that of the wild-type receptor and exhibited a Kd value for [3H]PGE2 binding similar to that of the wild-type receptor. PGE2-mediated adenylyl cyclase activity as a function of PGE2 concentration was similar in cells expressing the wild-type and truncated EP4 receptors. Neither the wild-type receptor nor the truncated form showed any constitutive activity. However, the wild-type EP4 receptor underwent PGE2-induced desensitization fully within 15-20 min, whereas the truncated EP4 receptor, lacking 36 of the 38 carboxyl-terminal serines and threonines, displayed a sustained activation. Despite the continuous presence of PGE2, the rate of cAMP synthesis via stimulation of the truncated receptor remained constant over >= 20 min. These findings suggest that the cytoplasmic tail of EP4 plays an important role in agonist-induced desensitization.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
HypertensionHome page
A.-M. Hristovska, L. E. Rasmussen, P. B.L. Hansen, S. S. Nielsen, R. M. Nusing, S. Narumiya, P. Vanhoutte, O. Skott, and B. L. Jensen
Prostaglandin E2 Induces Vascular Relaxation by E-Prostanoid 4 Receptor-Mediated Activation of Endothelial Nitric Oxide Synthase
Hypertension, September 1, 2007; 50(3): 525 - 530.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
U. G. Friis, J. Stubbe, T. R. Uhrenholt, P. Svenningsen, R. M. Nusing, O. Skott, and B. L. Jensen
Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells
Am J Physiol Renal Physiol, November 1, 2005; 289(5): F989 - F997.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. W. Beukers, J. van Oppenraaij, P. P. W. van der Hoorn, C. C. Blad, H. d. Dulk, J. Brouwer, and A. P. IJzerman
Random Mutagenesis of the Human Adenosine A2B Receptor Followed by Growth Selection in Yeast. Identification of Constitutively Active and Gain of Function Mutations
Mol. Pharmacol., March 1, 2004; 65(3): 702 - 710.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. Unmack, P. K. Rangachari, and E. Skadhauge
Effects of Isoprostanes and Prostanoids on Porcine Small Intestine
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 434 - 441.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
S. Desai, H. April, C. Nwaneshiudu, and B. Ashby
Comparison of Agonist-Induced Internalization of the Human EP2 and EP4 Prostaglandin Receptors: Role of the Carboxyl Terminus in EP4 Receptor Sequestration
Mol. Pharmacol., April 13, 2001; 58(6): 1279 - 1286.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
P.-Y. Law, L. J. Erickson, R. El-Kouhen, L. Dicker, J. Solberg, W. Wang, E. Miller, A. L. Burd, and H. H. Loh
Receptor Density and Recycling Affect the Rate of Agonist-Induced Desensitization of {micro}-Opioid Receptor
Mol. Pharmacol., August 1, 2000; 58(2): 388 - 398.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. D. Breyer and R. M. Breyer
Prostaglandin E receptors and the kidney
Am J Physiol Renal Physiol, July 1, 2000; 279(1): F12 - F23.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. E. Moore, J. D. Laporte, S. Gonzalez, W. Moller, J. Heyder, R. A. Panettieri Jr., and S. A. Shore
Glucocorticoids ablate IL-1beta -induced beta -adrenergic hyporesponsiveness in human airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, November 1, 1999; 277(5): L932 - L942.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. A. Stillman, M. D. Breyer, and R. M. Breyer
Importance of the Extracellular Domain for Prostaglandin EP2 Receptor Function
Mol. Pharmacol., September 1, 1999; 56(3): 545 - 551.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
F. Neuschäfer-Rube, M. Oppermann, U. Möller, U. Böer, and G. P. Püschel
Agonist-Induced Phosphorylation by G Protein-Coupled Receptor Kinases of the EP4 Receptor Carboxyl-Terminal Domain in an EP3/EP4 Prostaglandin E2 Receptor Hybrid
Mol. Pharmacol., August 1, 1999; 56(2): 419 - 428.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
E. M. Smyth, W. H. Li, and G. A. FitzGerald
Phosphorylation of the Prostacyclin Receptor during Homologous Desensitization. A CRITICAL ROLE FOR PROTEIN KINASE C
J. Biol. Chem., September 4, 1998; 273(36): 23258 - 23266.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P.-Y. Law, O. M.-E. Kouhen, J. Solberg, W. Wang, L. J. Erickson, and H. H. Loh
Deltorphin II-induced Rapid Desensitization of delta -Opioid Receptor Requires Both Phosphorylation and Internalization of the Receptor
J. Biol. Chem., October 6, 2000; 275(41): 32057 - 32065.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics